POINT ROBERTS, Wash. and DELTA, British Columbia, Jan. 24, 2019 (GLOBE NEWSWIRE) -- Investorideas.com, a leading investor news resource covering
hemp and cannabis stocks continues with part two of its series on companies targeting the global CBD pet market and what’s driving
this sector.
Recently the ‘Chicago Tribune’ reported “Looking to relieve her miniature dachshund Parky’s arthritis, mother of two Teressa Sworsky discovered hemp
oil.” When your wife is selling it and your dog is taking it, it’s time to do your research. CBD is hitting target
consumers in a big way – women and their pets!
Even Vanity Fair is talking about the CBD pet market. In an article in December, they reported, “CBD has infiltrated
wellness products of all kinds for humans. Pets were probably the inevitable next frontier.”
Marking their territory, Isodiol International (CSE: ISOL) (OTCQB: ISOLF), focused
on the nutritional health benefits derived from hemp, last October announced the launch of Pawceuticals, a CBD-based product line that naturally aids in
restoring a pet’s health and improving overall wellness.
As for what drove them to this sector, CEO Marcos Agramont said, “Pet owners are more passionate than ever about the health and wellness of their pets. Pet
owners today prefer products that are all natural and less harmful than standard veterinary prescribed medications. CBD offers
powerful benefits especially when combined with other adaptogens to help maintain and improve pet health and overall wellness
without producing unwanted side effects.”
SinglePoint (OTCQB: SING), mentioned in Part 1 of our
series, remains in a unique position in the emerging CBD space. As both an online marketer and payments
processor, the company looks to be in a strong position to help deliver CBD products to their target markets. Unlike many of the
other publicly traded, cannabis-focused companies, SinglePoint has no connection with cannabis plants and cultivation, so the
company should be able to take full advantage of the recently passed 2018 Farm Bill.
SinglePoint’s subsidiary SingleSeed recently launched PHYTO-BITES on SingleSeed.com to target the growing CBD pet market, saying on the SingleSeed blog ‘CBD for
Pets’ – “We love our pets. Raising pets like they are members of our families means we go the extra mile for them; especially
when it comes time to address their health problems. More and more pet owners are turning to CBD to help their buddies in similar
fashions. Phyto-Bites CBD Soft Chews are for use in dogs and are formulated to promote health and support the reduction of
separation anxiety, pain and inflammation.”
This passion for animals seems to be the biggest factor separating the CBD pet sector from the CBD market in general.
True Leaf Medicine International (CSE:MJ) (OTC:TRLFF), a global cannabis and hemp wellness brand for pets, announced in
December that the Company donated $10,000 (USD) to the Hemp Feed Coalition to advance its efforts to engage the US.FDA on new
uses of hemp for pets.
The Hemp Feed Coalition, (includes True Leaf), is a diverse group of industry stakeholders such as hemp producers,
veterinarians, regulatory bodies, retailers, colleges, and universities. Its goal is to obtain US Food and Drug Administration and
Center for Veterinary Medicine (FDA-CVM) approval of new uses for hemp grain products in pet food and animal feed. While the Farm
Bill legalizes hemp and recognizes it as an agricultural product, the FDA-CVM must still approve new pet products with added
hemp.
True Leaf’s True Hemp™ pet supplements are currently on shelves in PetSmart Canada, Pet Supplies Plus USA, Pets Corner UK, and
Das Futterhaus in Germany.
As demand grows for CBD pet products, companies must look to distribution as well as production. Dixie Brands (CSE: DIXI.U),
one of the cannabis industry's consumer packaged goods companies, recently announced new leadership and priorities for its pet wellness company, Therabis. Dixie
hired specialty pet food and CPG veteran Bob Rubin as the first President of Therabis, with the objective of significantly growing
the brand's retail presence and sales.
Therabis plans to significantly expand its "bricks and mortar" presence in 2019 to complement its successful e-commerce
platform, www.therabis.com and recently signed an
agreement with Central Garden & Pet, a distributor with access to thousands of retail locations nationwide.
As online and retail sales deals like this emerge, the big question is ‘when will online retailers like Amazon will officially
sell CBD pet products?’ There are currently a small portfolio of products available on Amazon here, though the efficacy and legitimacy of products is in question. Amazon has made no
statement regarding their online sales of CBD, but perhaps that is only a matter of time...
Read part one of the series on CBD pet markets.
For investors following cannabis stocks, Investor Ideas has created a stock directory of publicly traded CSE, TSX,
TSXV, OTC, NASDAQ, NYSE, ASX Marijuana/Hemp Stocks
About Investorideas.com
https://www.investorideas.com/About/
Follow us on Cannabis Social Media
https://www.facebook.com/Investorideaspotcasts/
https://twitter.com/MJInvestorIdeas
https://www.instagram.com/potcasts_investorideas/
Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as
creates original content, including video, interviews and articles. Our site does not make recommendations for purchases or sale of
stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or
securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication
and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press
release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the
news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp. Disclosure: this news article featuring SING is a paid for
news release on Investorideas.com. Learn more about costs and our services https://www.investorideas.com/News-Upload/
Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Contact Investorideas.com
800-665-0411
